Jpmorgan Chase & Co »

Gracell Biotechnologies shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $141k 14k 10.04
2023-09-30 $37k 13k 2.88
2023-06-30 $8.6k 2.3k 3.81
2023-03-31 $4.0k 2.2k 1.82
2022-12-31 $5.0k 2.0k 2.47
2022-06-30 $16k 2.8k 5.62
2022-03-31 $14k 6.1k 2.31
2021-12-31 $27k 4.4k 6.12